4-chloro-N-(3-morpholinopropyl)benzamide,
befol,
befol monohydrochloride,
LIS 630,
LIS-630,
Eprobemide,
87940-60-1,
UNII-URX5F7RDER,
URX5F7RDER,
4-chloro-N-(3-morpholin-4-ylpropyl)benzamide,
4-chloro-N-[3-(morpholin-4-yl)propyl]benzamide,
NCGC00164516-01,
NCGC00164516-02,
DSSTox_CID_26409,
DSSTox_RID_81588,
DSSTox_GSID_46409,
Eprobemida,
Eprobemidum,
Eprobemide [INN],
CAS-87940-60-1,
Eprobemidum [INN-Latin],
Eprobemida [INN-Spanish],
befole,
CBMicro_028607,
AC1L23PH,
SCHEMBL570896,
CHEMBL2104298,
DTXSID3046409,
LIS 630,
YYFGRAGNYHYWEZ-UHFFFAOYSA-N,
Eprobemide (Synonyms: LIS 630),
HY-B1413,
Tox21 112151,
Tox21_112151,
STK415747,
ZINC19593518,
AKOS002663030,
Tox21_112151_1,
CCG-213898,
MCULE-5197596883,
p-Chloro-N-(3-morpholinopropyl)benzamide,
BIM-0028524.P001,
CS-0013131,
ST50915492,
AB00093932-01,
AB00093932_02,
SR-01000944262,
SR-01000944262-1,
(4-chlorophenyl)-N-(3-morpholin-4-ylpropyl)carboxamide,
F1018-1170,
Befol,
C14-H19-Cl-N2-O2,
CID65659,